Press release
Dentsply Sirona Reports Preliminary First Quarter 2022 Results
Net sales decreased (6.1%) to $965 million, organic sales decreased (1.4%)Operating income of $93 million, adjusted operating income of $153 millionEPS of
About this update from Dentsply Sirona Inc.
[{"type":"text","content":"Net sales decreased (6.1%) to $965 million, organic sales decreased (1.4%)Operating income of $93 million, adjusted operating income of $153 millionEPS of $0.30, adjusted EPS decreased to $0.52 vs $0.72 in Q1 2021Operating cash flow increased to $93 million vs $49 million in Q1 2021Updated FY22 outlook: organic sales growth of 2% to 3%; adj. EPS range of $2.35 to $2.55Delays filing of Form 10-Q as previously communicated in the Company's filing of a Form 12b-25 CHARLOTTE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the \"Company\") (Nasdaq: XRAY) today announced its preliminary financial results for the first quarter of 2022. First quarter net sales of $965 million decreased (6.1%), compared to $1,027 million in the first quarter of 2021. Net income for the first quarter of 2022 was $65 million, or $0.30 per diluted share, compared to $117 million, or $0.53 per diluted share in the first quarter of 2021. Adjusted earnings per diluted share decreased to $0.52 compared to $0.72 in the first quarter of 2021. A reconciliation of Non-GAAP measures (including organic sales, adjusted operating income and margin, adjusted EPS, and adjusted EBITDA) to GAAP measures is provided below. “The first quarter was a challenging quarter, and our financial performance and revised outlook reflect the impact of larger-than-expected macroeconomic headwinds and lower-than-expected performance in the United States. Despite these challenges, organic growth in Europe was robust, demand remains strong, and our teams are working diligently to reduce lead times to address supply chain challenges,\" said John Groetelaars, Interim Chief Executive Officer. \"We are confident in our ability to address these transient headwinds and we have high conviction about our future. Dental remains an attractive market. We have a healthy innovation pipeline, leading digital capabilities, and a well-positioned portfolio which will drive sustainable growth long-term.\" Q1 22 Summary Results (GAAP) (in millions, except per share amount and percentages) Q1 22 Q1 21 YoYNet Sales 965 1,027 (6.1%)Operating Income 93 154 (39.5%)Operating Income % 9.7% 15.0% Diluted EPS 0.30 0.53 (43.8%) * Percentages are based on actual values and may not recalculate due to rounding. Q1 22 Summary Results (Non-GAAP)[1] (in millions, except per share amount and...